Senseonics Holdings (SENS) Invested Capital (2015 - 2019)

Senseonics Holdings' (SENS) quarterly Invested Capital came in at $60.4 million in Q4 2019, up 670488.89% on a QoQ basis from $9000.0 in Q3 2015.

Senseonics Holdings (SENS) Invested Capital (2015 - 2019) Analysis & Trends

Senseonics Holdings (SENS) has 2 years of Invested Capital data on file, last reported at $60.4 million in Q4 2019.

  • On a quarterly basis, Invested Capital changed N/A year-over-year to $60.4 million in Q4 2019; TTM through Sep 2020 was $60.4 million, a N/A change from a year earlier, with the FY2019 full-year figure at $60.4 million, changed N/A from the prior year.
  • Invested Capital for Q4 2019 stood at $60.4 million, up from $9000.0 in the prior quarter.
  • Over the last five years, Invested Capital for SENS reached as high as $60.4 million in Q4 2019 and fell as low as $9000.0 in Q3 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 4.41 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 499.00 Mn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 1.79 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 1.41 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 7.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 15.00 Mn
10 Senseonics Holdings 203.54 Mn 139.22 Mn 6.94 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 60.35 Mn
Sep 30, 2015 9,000.00